Bio/Med Investor Network

Bio/Med Investor Network

Bio/Med Investor Network was established in Atlanta to connect accredited investors with vetted opportunities in biotechnology, medical devices, and healthcare services. The firm functions as an angel network, bringing together physicians, healthcare executives, and experienced private investors who evaluate startups alongside domain experts before committing capital collectively. The network targets pre-seed through Series A rounds, writing checks that typically range from $50,000 to $250,000 per participating member. Deal flow originates from university tech transfer offices, regional incubators, and referrals through the membership base. Investment focus spans therapeutic platforms, diagnostic tools, and digital health applications. The group favors capital-efficient models with clear regulatory pathways. Bio/Med Investor Network operates without a permanent pool of committed capital — each investment is syndicated on a deal-by-deal basis among members. The structure sidesteps management fees and carried interest, with members paying an annual membership fee for access to curated deal flow, due diligence materials, and quarterly pitch events. The network does not publish aggregate deployment figures. The network's structural distinction lies in its operator-centric membership base — most members are practicing clinicians or former healthcare founders who contribute both capital and domain validation. This peer-review model creates a sourcing advantage in a sector where technical diligence often requires specialized expertise that generalist angel groups cannot provide.